title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal,20240904T153200,https://www.zacks.com/stock/news/2331539/atha-stock-tanks-as-alzheimers-study-fails-to-meet-primary-goal,PRTA,0.084423,Neutral,0.120998
Eli Lilly  ( LLY )  Gets FDA Nod for Alzheimer's Drug Donanemab,20240703T123400,https://www.zacks.com/stock/news/2296481/eli-lilly-lly-gets-fda-nod-for-alzheimers-drug-donanemab,PRTA,0.165788,Neutral,0.0
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?,20240619T170000,https://www.zacks.com/stock/news/2290613/can-eli-lilly-etfs-surge-on-approval-of-alzheimers-drug,PRTA,0.250386,Neutral,0.0
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab  ( Revised ) ,20240614T152100,https://www.zacks.com/stock/news/2288637/alzheimers-in-focus-as-fda-panel-endorses-lillys-donanemab-revised,PRTA,0.146916,Neutral,0.06373
"The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune  ( Revised ) ",20240614T151000,https://www.zacks.com/stock/news/2288638/the-zacks-analyst-blog-highlights-biogen-eli-lillys-prothena-and-ac-immune-revised,PRTA,0.176502,Neutral,0.040747
"The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune",20240613T100900,https://www.zacks.com/stock/news/2287623/the-zacks-analyst-blog-highlights-biogen-eli-lillys-prothena-and-ac-immune,PRTA,0.18046,Neutral,0.041398
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab,20240612T142200,https://www.zacks.com/stock/news/2287324/alzheimers-in-focus-as-fda-panel-endorses-lillys-donanemab,PRTA,0.150592,Neutral,0.064671
"The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity",20231212T141000,https://www.zacks.com/stock/news/2196695/the-zacks-analyst-blog-highlights-biogen-prothena-ac-immunes-and-vaxxinity,PRTA,0.212674,Neutral,0.08018
Alzheimer's Disease Space Evolves in 2023: Stocks in Focus,20231211T140600,https://www.zacks.com/stock/news/2196083/alzheimers-disease-space-evolves-in-2023-stocks-in-focus,PRTA,0.181819,Neutral,0.109759
"Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others - Biogen  ( NASDAQ:BIIB ) ",20231121T201625,https://www.benzinga.com/general/biotech/23/11/35901610/alzheimers-disease-vaccines-promising-developments-renewed-enthusiasm-from-biogen-eli-lilly-and-o,PRTA,0.229149,Somewhat-Bullish,0.303386
"Researchers return to Alzheimer's vaccines, buoyed by recent drug success",20231120T111500,https://www.reuters.com/business/healthcare-pharmaceuticals/researchers-return-alzheimers-vaccines-buoyed-by-recent-drug-success-2023-11-20/,PRTA,0.165598,Neutral,0.084646
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win - Biogen  ( NASDAQ:BIIB ) ,20220928T201722,https://www.benzinga.com/general/biotech/22/09/29061026/these-stocks-are-on-the-radar-after-biogen-eisais-surprising-alzheimers-trial-win,PRTA,0.112269,Neutral,0.0
"Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket - AIM ImmunoTech  ( AMEX:AIM ) , Acumen Pharmaceuticals  ( NASDAQ:ABOS ) ",20220928T111722,https://www.benzinga.com/news/22/09/29048520/why-mindmed-is-trading-lower-by-around-35-here-are-31-stocks-moving-premarket,PRTA,0.102013,Somewhat-Bullish,0.184506
"Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics  ( NASDAQ:ALDX ) , Alignment Healthcare  ( NASDAQ:ALHC ) ",20231016T170953,https://www.benzinga.com/news/23/10/35272489/why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in,PRTA,0.076236,Somewhat-Bullish,0.348025
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,PRTA,0.009551,Neutral,0.0
"Stocks That Hit 52-Week Lows On Thursday - PRA Group  ( NASDAQ:PRAA ) , Perimeter Solutions  ( NYSE:PRM ) ",20231005T172202,https://www.benzinga.com/news/23/10/35111787/stocks-that-hit-52-week-lows-on-thursday,PRTA,0.013047,Neutral,-0.083761
"Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday - AAR  ( NYSE:AIR ) , Boeing  ( NYSE:BA ) ",20240108T164604,https://www.benzinga.com/news/24/01/36538431/boeing-pacific-biosciences-of-california-and-other-big-stocks-moving-lower-on-monday,PRTA,0.215894,Somewhat-Bearish,-0.244975
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,PRTA,0.024347,Neutral,0.051825
"Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon",20230726T210100,https://www.prnewswire.com/news-releases/dementia-market-to-grow-rapidly-estimates-delveinsight--key-companies-active-in-the-market---pfizer-eli-lilly-and-company-janssen-merck-biovie-biogen-vivoryon-sage-alnylam-bioxcel-eip-otsuka-alector-transposon-301885979.html,PRTA,0.047607,Neutral,0.049275
"Earnings Scheduled For May 5, 2022",20220505T084322,https://www.benzinga.com/news/earnings/22/05/27012606/earnings-scheduled-for-may-5-2022,PRTA,0.009774,Neutral,-0.015641
"PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday - PROCEPT BioRobotics  ( NASDAQ:PRCT ) ",20241028T141458,https://www.benzinga.com/news/earnings/24/10/41576730/procept-biorobotics-posts-strong-q3-earnings-joins-monte-rosa-therapeutics-eyepoint-pharmaceuticals,PRTA,0.198221,Neutral,0.0
